IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q3 2013 Holdings

Filed 2013-11-14 | 2 holdings | $149.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synta Pharmaceuticals CorpCOM87162T206$149.1K23,634,34999.9%
Hallmark Finl Svcs Inc ECCOM NEW40624Q203$19421,9250.1%